Reported Earnings • May 26
First quarter 2026 earnings released First quarter 2026 results: EPS: US$0.03. Revenue: US$31.9m (up 85% from 1Q 2025). Net income: US$3.36m (up 178% from 1Q 2025). Profit margin: 11% (up from 7.0% in 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 116 percentage points per year, which is a significant difference in performance. New Risk • May 25
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Israeli stocks, typically moving 7.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 48% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.4% average weekly change). Shareholders have been diluted in the past year (17% increase in shares outstanding). Announcement • May 07
TopGum Industries Ltd. (TASE:TPGM) completed the acquisition of US operations of manufacturing nutritional supplements and pharmaceuticals in the form of gummies from P&L Development, LLC for $35 million. TopGum Industries Ltd. (TASE:TPGM) signed a letter of intent to acquire US operations of manufacturing nutritional supplements and pharmaceuticals in the form of gummies from P&L Development, LLC for $37 million on January 19, 2026. A cash consideration of $12 million will be paid by TopGum Industries Ltd. The consideration consists of common equity of TopGum Industries Ltd. having a value of $13 million to be issued for assets of US operations of manufacturing nutritional supplements and pharmaceuticals in the form of gummies. As part of consideration, $37 million is paid towards assets of US operations of manufacturing nutritional supplements and pharmaceuticals in the form of gummies. In case of termination of transaction, TopGum Industries Ltd. will pay a termination fee of $0.32 million and seller will pay a termination fee of $0.32 million.
The transaction is subject to approval by regulatory board / committee, consummation of due diligence investigation and definitive agreement.
TopGum Industries Ltd. (TASE:TPGM) completed the acquisition of US operations of manufacturing nutritional supplements and pharmaceuticals in the form of gummies from P&L Development, LLC for $35 million on May 05, 2026. The consideration consists of $10 million in cash and 1,893,060 shares of TopGum valued at approximately $8.8 million. The agreement also includes a contingent consideration of up to 4,022,751 additional shares, valued at up to $18.7 million, payable upon the achievement of certain commercial and regulatory milestones. 
